These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
351 related articles for article (PubMed ID: 19620490)
1. Presentation of nonfinal results of randomized controlled trials at major oncology meetings. Booth CM; Le Maître A; Ding K; Farn K; Fralick M; Phillips C; Cescon DW; Meyer RM J Clin Oncol; 2009 Aug; 27(24):3938-44. PubMed ID: 19620490 [TBL] [Abstract][Full Text] [Related]
2. Reporting of trials presented in conference abstracts needs to be improved. Hopewell S; Clarke M; Askie L J Clin Epidemiol; 2006 Jul; 59(7):681-4. PubMed ID: 16765270 [TBL] [Abstract][Full Text] [Related]
3. Reporting quality and information consistency of randomized, controlled trials presented as abstracts at the American Urological Association annual meetings. Turpen RM; Fesperman SF; Smith WA; Vieweg J; Dahm P J Urol; 2010 Jul; 184(1):249-53. PubMed ID: 20483151 [TBL] [Abstract][Full Text] [Related]
4. Quality of abstracts describing randomized trials in the proceedings of American Society of Clinical Oncology meetings: guidelines for improved reporting. Krzyzanowska MK; Pintilie M; Brezden-Masley C; Dent R; Tannock IF J Clin Oncol; 2004 May; 22(10):1993-9. PubMed ID: 15143092 [TBL] [Abstract][Full Text] [Related]
5. Evolution of the randomized controlled trial in oncology over three decades. Booth CM; Cescon DW; Wang L; Tannock IF; Krzyzanowska MK J Clin Oncol; 2008 Nov; 26(33):5458-64. PubMed ID: 18955452 [TBL] [Abstract][Full Text] [Related]
6. Discordance between conclusions stated in the abstract and conclusions in the article: analysis of published randomized controlled trials of systemic therapy in lung cancer. Altwairgi AK; Booth CM; Hopman WM; Baetz TD J Clin Oncol; 2012 Oct; 30(28):3552-7. PubMed ID: 22649130 [TBL] [Abstract][Full Text] [Related]
7. Presentation and subsequent publication rates of phase I oncology clinical trials. Camacho LH; Bacik J; Cheung A; Spriggs DR Cancer; 2005 Oct; 104(7):1497-504. PubMed ID: 16116590 [TBL] [Abstract][Full Text] [Related]
9. Publication rate of abstracts from the annual ASTRO meeting: comparison with other organizations. Papagikos MA; Rossi PJ; Lee WR J Am Coll Radiol; 2005 Jan; 2(1):72-5. PubMed ID: 17411764 [TBL] [Abstract][Full Text] [Related]
10. [The impact of the annual scientific meetings of the Israel Society of Rheumatology as measured by publication rates of the abstracts in peer-reviewed journals]. Perez S; Hashkes PJ; Uziel Y Harefuah; 2004 Apr; 143(4):266-9, 319. PubMed ID: 15116582 [TBL] [Abstract][Full Text] [Related]
11. Transition from meeting abstract to full-length journal article for randomized controlled trials. Toma M; McAlister FA; Bialy L; Adams D; Vandermeer B; Armstrong PW JAMA; 2006 Mar; 295(11):1281-7. PubMed ID: 16537738 [TBL] [Abstract][Full Text] [Related]
12. Publication outcomes of phase II oncology clinical trials. Hoeg RT; Lee JA; Mathiason MA; Rokkones K; Serck SL; Crampton KL; Emmel AE; Severson EA; Go RS Am J Clin Oncol; 2009 Jun; 32(3):253-7. PubMed ID: 19349853 [TBL] [Abstract][Full Text] [Related]
13. Discrepancies and rates of publication in orthopaedic sports medicine abstracts. Kleweno CP; Bryant WK; Jacir AM; Levine WN; Ahmad CS Am J Sports Med; 2008 Oct; 36(10):1875-9. PubMed ID: 18667625 [TBL] [Abstract][Full Text] [Related]
14. Improving the quality of abstract reporting for phase I cancer trials. Strevel EL; Chau NG; Pond GR; Murgo AJ; Ivy PS; Siu LL Clin Cancer Res; 2008 Mar; 14(6):1782-7. PubMed ID: 18347180 [TBL] [Abstract][Full Text] [Related]
15. Factors associated with the full publication of studies presented in abstract form at the annual meeting of the American Urological Association. Smith WA; Cancel QV; Tseng TY; Sultan S; Vieweg J; Dahm P J Urol; 2007 Mar; 177(3):1084-8; discussion 1088-9. PubMed ID: 17296415 [TBL] [Abstract][Full Text] [Related]
16. The quality of reporting of trial abstracts is suboptimal: survey of major general medical journals. Berwanger O; Ribeiro RA; Finkelsztejn A; Watanabe M; Suzumura EA; Duncan BB; Devereaux PJ; Cook D J Clin Epidemiol; 2009 Apr; 62(4):387-92. PubMed ID: 19010643 [TBL] [Abstract][Full Text] [Related]
17. [Publication rate for oral presentations made at the Journées Dermatologiques de Paris meeting]. Bolac C; Orosco A; Guillet G; Quist D; Derancourt C Ann Dermatol Venereol; 2009 Jan; 136(1):21-7. PubMed ID: 19171225 [TBL] [Abstract][Full Text] [Related]
18. The consistency between scientific papers presented at the Orthopaedic Trauma Association and their subsequent full-text publication. Preston CF; Bhandari M; Fulkerson E; Ginat D; Egol KA; Koval KJ J Orthop Trauma; 2006 Feb; 20(2):129-33. PubMed ID: 16462566 [TBL] [Abstract][Full Text] [Related]
19. Delay and failure to publish dental research. Scholey JM; Harrison JE Evid Based Dent; 2005; 6(3):58-61. PubMed ID: 16184153 [TBL] [Abstract][Full Text] [Related]
20. Statistical power of negative randomized controlled trials presented at American Society for Clinical Oncology annual meetings. Bedard PL; Krzyzanowska MK; Pintilie M; Tannock IF J Clin Oncol; 2007 Aug; 25(23):3482-7. PubMed ID: 17687153 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]